Abionyx Pharma (EURONEXT:ABNX)

European company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ABNX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ABNX

  • Market Cap€29.560m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINFR0012616852

Company Profile

Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.Cerenis Therapeutics Holding SA is a biopharmaceutical company dedicated to the discovery and development of HDL therapies (good cholesterol) for treating cardiovascular and metabolic diseases.

Latest ABNX news

Currently there for this company. Visit our news hub for other news .